Adma Biologics (ADMA) Income After Tax (2011 - 2026)
Adma Biologics (ADMA) recorded Income After Tax of $49.88 million in Q3 2026, up 36.9% from $36.43 million a year earlier and up 31.9% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Income After Tax (2011 - 2026) Analysis & Trends
On a TTM basis, Adma Biologics' Income After Tax came in at $182.41 million as of Sep 30, 2026, down 12.9% year-over-year; for FY2025, it was $146.93 million, down 25.7% from FY2024.
- Across earlier years, Income After Tax came in at $197.67 million in FY2024, -$28.24 million in FY2023, -$65.9 million in FY2022 and -$71.4 million in FY2021.
- The Q3 2026 figure is the highest quarterly Income After Tax since Q4 2024.
- On a year-over-year basis, Income After Tax has increased for three consecutive quarters, with growth averaging 17.0% over the last seven quarters.
- Per Business Quant, the preceding three quarters came in at $37.82 million (Q2 2026), $45.33 million (Q1 2026) and $49.38 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 49.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 49.88 Mn |
| Jun 30, 2026 | 37.82 Mn |
| Mar 31, 2026 | 45.33 Mn |
| Dec 31, 2025 | 49.38 Mn |
| Sep 30, 2025 | 36.43 Mn |
| Jun 30, 2025 | 34.22 Mn |
| Mar 31, 2025 | 26.90 Mn |
| Dec 31, 2024 | 111.90 Mn |
| Sep 30, 2024 | 35.91 Mn |
| Jun 30, 2024 | 32.06 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | -17.65 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | -6.37 Mn |
| Mar 31, 2023 | -6.79 Mn |
| Dec 31, 2022 | -11.79 Mn |
| Sep 30, 2022 | -14.89 Mn |
| Jun 30, 2022 | -13.75 Mn |
| Mar 31, 2022 | -18.17 Mn |
| Dec 31, 2021 | -16.50 Mn |
API Access
Adma Biologics Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();